82 FR 71 pgs. 17995-17996 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
Type: NOTICEVolume: 82Number: 71Pages: 17995 - 17996
Pages: 17995, 17996FR document: [FR Doc. 2017-07595 Filed 4-13-17; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
[top] The meeting announced below concerns the Centers for Disease Control and Prevention (CDC) initial review of applications in response to Funding Opportunity Announcement (FOA) GH17-002, Program Development and Research to Establish and Evaluate Innovative and Emerging Best Practices in Clinical and Community Services through the Presidents Emergency Plan for AIDS Relief (PEPFAR); GH17-003,
Summary: This publication corrects a notice that was published in the Federal Register on April 4, 2017, Volume 82, Number 63, page 16403. The meeting announcement, meeting date, and matters for discussion should read as follows:
The meeting announced below concerns the Centers for Disease Control and Prevention (CDC) initial review of applications in response to Funding Opportunity Announcements GH17-002, Program Development and Research to Establish and Evaluate Innovative and Emerging Best Practices in Clinical and Community Services through the President's Emergency Plan for AIDS Relief (PEPFAR); and GH17-003, Conducting Public Health Research in South Africa.
Time and Date: 9:00 a.m.-2:00 p.m., EDT, April 25, 2017, Panel A (Closed).
Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to "Program Development and Research to Establish and Evaluate Innovative and Emerging Best Practices in Clinical and Community Services through the President's Emergency Plan for AIDS Relief (PEPFAR)", FOA GH17-002; and "Conducting Public Health Research in South Africa", FOA GH17-003.
For Further Information Contact: Hylan Shoob, Scientific Review Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 Clifton Road NE., Mailstop D-69, Atlanta, Georgia 30033, Telephone: (404) 639-4796, HSHOOB@CDC.GOV.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2017-07595 Filed 4-13-17; 8:45 am]
BILLING CODE 4163-18-P